nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—NPPB—pulmonary artery—Behcet's disease	0.053	0.092	CbGeAlD
Carvedilol—SELE—vein—Behcet's disease	0.0326	0.0566	CbGeAlD
Carvedilol—VCAM1—vein—Behcet's disease	0.03	0.052	CbGeAlD
Carvedilol—NPPB—artery—Behcet's disease	0.0196	0.0341	CbGeAlD
Carvedilol—NPPB—blood vessel—Behcet's disease	0.0153	0.0266	CbGeAlD
Carvedilol—SELE—artery—Behcet's disease	0.0133	0.023	CbGeAlD
Carvedilol—VCAM1—artery—Behcet's disease	0.0122	0.0212	CbGeAlD
Carvedilol—HIF1A—artery—Behcet's disease	0.0117	0.0204	CbGeAlD
Carvedilol—GJA1—artery—Behcet's disease	0.0114	0.0198	CbGeAlD
Carvedilol—SELE—endothelium—Behcet's disease	0.0112	0.0195	CbGeAlD
Carvedilol—SELE—blood vessel—Behcet's disease	0.0103	0.0179	CbGeAlD
Carvedilol—VCAM1—endothelium—Behcet's disease	0.0103	0.0179	CbGeAlD
Carvedilol—HIF1A—endothelium—Behcet's disease	0.00992	0.0172	CbGeAlD
Carvedilol—GJA1—endothelium—Behcet's disease	0.00962	0.0167	CbGeAlD
Carvedilol—VCAM1—blood vessel—Behcet's disease	0.00951	0.0165	CbGeAlD
Carvedilol—HIF1A—blood vessel—Behcet's disease	0.00915	0.0159	CbGeAlD
Carvedilol—GJA1—blood vessel—Behcet's disease	0.00888	0.0154	CbGeAlD
Carvedilol—VCAM1—mouth—Behcet's disease	0.00796	0.0138	CbGeAlD
Carvedilol—HIF1A—mouth—Behcet's disease	0.00766	0.0133	CbGeAlD
Carvedilol—GJA1—mouth—Behcet's disease	0.00743	0.0129	CbGeAlD
Carvedilol—NDUFC2—mouth—Behcet's disease	0.00646	0.0112	CbGeAlD
Carvedilol—NPPB—cardiac atrium—Behcet's disease	0.00619	0.0107	CbGeAlD
Carvedilol—VCAM1—eye—Behcet's disease	0.00506	0.00879	CbGeAlD
Carvedilol—VCAM1—retina—Behcet's disease	0.00502	0.00871	CbGeAlD
Carvedilol—HIF1A—brainstem—Behcet's disease	0.005	0.00868	CbGeAlD
Carvedilol—HIF1A—eye—Behcet's disease	0.00487	0.00845	CbGeAlD
Carvedilol—GJA1—brainstem—Behcet's disease	0.00485	0.00842	CbGeAlD
Carvedilol—HIF1A—retina—Behcet's disease	0.00483	0.00838	CbGeAlD
Carvedilol—SELE—skin of body—Behcet's disease	0.00479	0.00831	CbGeAlD
Carvedilol—GJA1—eye—Behcet's disease	0.00472	0.0082	CbGeAlD
Carvedilol—GJA1—retina—Behcet's disease	0.00468	0.00813	CbGeAlD
Carvedilol—NPPB—nervous system—Behcet's disease	0.00438	0.00761	CbGeAlD
Carvedilol—SELE—mammalian vulva—Behcet's disease	0.00437	0.00758	CbGeAlD
Carvedilol—HIF1A—skin of body—Behcet's disease	0.00424	0.00735	CbGeAlD
Carvedilol—NPPB—central nervous system—Behcet's disease	0.00422	0.00733	CbGeAlD
Carvedilol—NDUFC2—eye—Behcet's disease	0.00411	0.00714	CbGeAlD
Carvedilol—GJA1—skin of body—Behcet's disease	0.00411	0.00713	CbGeAlD
Carvedilol—NDUFC2—retina—Behcet's disease	0.00407	0.00707	CbGeAlD
Carvedilol—VCAM1—mammalian vulva—Behcet's disease	0.00402	0.00697	CbGeAlD
Carvedilol—SELE—medulla oblongata—Behcet's disease	0.00394	0.00684	CbGeAlD
Carvedilol—HIF1A—mammalian vulva—Behcet's disease	0.00386	0.00671	CbGeAlD
Carvedilol—VCAM1—cardiac atrium—Behcet's disease	0.00385	0.00668	CbGeAlD
Carvedilol—GJA1—mammalian vulva—Behcet's disease	0.00375	0.00651	CbGeAlD
Carvedilol—HIF1A—cardiac atrium—Behcet's disease	0.0037	0.00642	CbGeAlD
Carvedilol—VCAM1—medulla oblongata—Behcet's disease	0.00363	0.00629	CbGeAlD
Carvedilol—SELE—midbrain—Behcet's disease	0.0036	0.00625	CbGeAlD
Carvedilol—GJA1—cardiac atrium—Behcet's disease	0.00359	0.00623	CbGeAlD
Carvedilol—SELE—spinal cord—Behcet's disease	0.00351	0.0061	CbGeAlD
Carvedilol—HIF1A—medulla oblongata—Behcet's disease	0.00349	0.00605	CbGeAlD
Carvedilol—GJA1—medulla oblongata—Behcet's disease	0.00338	0.00587	CbGeAlD
Carvedilol—NPPB—brain—Behcet's disease	0.00335	0.00582	CbGeAlD
Carvedilol—VCAM1—midbrain—Behcet's disease	0.00331	0.00575	CbGeAlD
Carvedilol—NDUFC2—mammalian vulva—Behcet's disease	0.00326	0.00566	CbGeAlD
Carvedilol—VCAM1—spinal cord—Behcet's disease	0.00323	0.00561	CbGeAlD
Carvedilol—HIF1A—midbrain—Behcet's disease	0.00319	0.00553	CbGeAlD
Carvedilol—NDUFC2—cardiac atrium—Behcet's disease	0.00312	0.00542	CbGeAlD
Carvedilol—HIF1A—spinal cord—Behcet's disease	0.00311	0.0054	CbGeAlD
Carvedilol—GJA1—midbrain—Behcet's disease	0.00309	0.00537	CbGeAlD
Carvedilol—GJA1—spinal cord—Behcet's disease	0.00302	0.00524	CbGeAlD
Carvedilol—SELE—nervous system—Behcet's disease	0.00296	0.00514	CbGeAlD
Carvedilol—VEGFA—mammalian vulva—Behcet's disease	0.00296	0.00514	CbGeAlD
Carvedilol—NDUFC2—medulla oblongata—Behcet's disease	0.00294	0.00511	CbGeAlD
Carvedilol—SELE—central nervous system—Behcet's disease	0.00285	0.00495	CbGeAlD
Carvedilol—VEGFA—cardiac atrium—Behcet's disease	0.00283	0.00492	CbGeAlD
Carvedilol—VCAM1—nervous system—Behcet's disease	0.00272	0.00473	CbGeAlD
Carvedilol—NDUFC2—midbrain—Behcet's disease	0.00269	0.00467	CbGeAlD
Carvedilol—XDH—mammalian vulva—Behcet's disease	0.00263	0.00457	CbGeAlD
Carvedilol—NDUFC2—spinal cord—Behcet's disease	0.00263	0.00456	CbGeAlD
Carvedilol—VCAM1—central nervous system—Behcet's disease	0.00262	0.00455	CbGeAlD
Carvedilol—HIF1A—nervous system—Behcet's disease	0.00262	0.00455	CbGeAlD
Carvedilol—GJA1—nervous system—Behcet's disease	0.00254	0.00441	CbGeAlD
Carvedilol—HIF1A—central nervous system—Behcet's disease	0.00252	0.00438	CbGeAlD
Carvedilol—GJA1—central nervous system—Behcet's disease	0.00245	0.00425	CbGeAlD
Carvedilol—PTGS1—artery—Behcet's disease	0.00242	0.0042	CbGeAlD
Carvedilol—VEGFA—spinal cord—Behcet's disease	0.00238	0.00414	CbGeAlD
Carvedilol—SELE—brain—Behcet's disease	0.00226	0.00393	CbGeAlD
Carvedilol—NDUFC2—nervous system—Behcet's disease	0.00221	0.00384	CbGeAlD
Carvedilol—NDUFC2—central nervous system—Behcet's disease	0.00213	0.0037	CbGeAlD
Carvedilol—VCAM1—brain—Behcet's disease	0.00208	0.00361	CbGeAlD
Carvedilol—PTGS1—endothelium—Behcet's disease	0.00204	0.00355	CbGeAlD
Carvedilol—HIF1A—brain—Behcet's disease	0.002	0.00348	CbGeAlD
Carvedilol—GJA1—brain—Behcet's disease	0.00194	0.00337	CbGeAlD
Carvedilol—PTGS1—blood vessel—Behcet's disease	0.00188	0.00327	CbGeAlD
Carvedilol—CYP1A1—mouth—Behcet's disease	0.00179	0.00312	CbGeAlD
Carvedilol—NDUFC2—brain—Behcet's disease	0.00169	0.00294	CbGeAlD
Carvedilol—VEGFA—brain—Behcet's disease	0.00153	0.00266	CbGeAlD
Carvedilol—ADRA1A—brainstem—Behcet's disease	0.00144	0.0025	CbGeAlD
Carvedilol—ADRB1—cardiac atrium—Behcet's disease	0.00134	0.00233	CbGeAlD
Carvedilol—ADRA1B—nervous system—Behcet's disease	0.00134	0.00233	CbGeAlD
Carvedilol—ADRA1D—nervous system—Behcet's disease	0.00131	0.00228	CbGeAlD
Carvedilol—ADRA1B—central nervous system—Behcet's disease	0.00129	0.00224	CbGeAlD
Carvedilol—ADRA1D—central nervous system—Behcet's disease	0.00126	0.00219	CbGeAlD
Carvedilol—ABCB1—blood vessel—Behcet's disease	0.00111	0.00193	CbGeAlD
Carvedilol—ADRA2C—mammalian vulva—Behcet's disease	0.00106	0.00184	CbGeAlD
Carvedilol—KCNH2—cardiac atrium—Behcet's disease	0.00103	0.00178	CbGeAlD
Carvedilol—ADRA1B—brain—Behcet's disease	0.00102	0.00178	CbGeAlD
Carvedilol—ADRA2C—cardiac atrium—Behcet's disease	0.00101	0.00176	CbGeAlD
Carvedilol—ADRA1D—brain—Behcet's disease	0.001	0.00174	CbGeAlD
Carvedilol—CYP1A1—skin of body—Behcet's disease	0.000993	0.00172	CbGeAlD
Carvedilol—KCNH2—medulla oblongata—Behcet's disease	0.000968	0.00168	CbGeAlD
Carvedilol—ADRA2C—medulla oblongata—Behcet's disease	0.000955	0.00166	CbGeAlD
Carvedilol—ADRB1—nervous system—Behcet's disease	0.000953	0.00165	CbGeAlD
Carvedilol—ADRB1—central nervous system—Behcet's disease	0.000917	0.00159	CbGeAlD
Carvedilol—CYP1A1—mammalian vulva—Behcet's disease	0.000906	0.00157	CbGeAlD
Carvedilol—KCNH2—midbrain—Behcet's disease	0.000885	0.00154	CbGeAlD
Carvedilol—ADRA2C—midbrain—Behcet's disease	0.000873	0.00152	CbGeAlD
Carvedilol—PTGS1—skin of body—Behcet's disease	0.000872	0.00151	CbGeAlD
Carvedilol—CYP1A1—cardiac atrium—Behcet's disease	0.000867	0.00151	CbGeAlD
Carvedilol—KCNH2—spinal cord—Behcet's disease	0.000863	0.0015	CbGeAlD
Carvedilol—ADRA2C—spinal cord—Behcet's disease	0.000852	0.00148	CbGeAlD
Carvedilol—CYP2D6—brainstem—Behcet's disease	0.000847	0.00147	CbGeAlD
Carvedilol—ADRA2A—mammalian vulva—Behcet's disease	0.000844	0.00147	CbGeAlD
Carvedilol—ADRA2A—cardiac atrium—Behcet's disease	0.000809	0.0014	CbGeAlD
Carvedilol—PTGS1—mammalian vulva—Behcet's disease	0.000796	0.00138	CbGeAlD
Carvedilol—ADRA2A—medulla oblongata—Behcet's disease	0.000762	0.00132	CbGeAlD
Carvedilol—PTGS1—cardiac atrium—Behcet's disease	0.000762	0.00132	CbGeAlD
Carvedilol—ADRA1A—nervous system—Behcet's disease	0.000753	0.00131	CbGeAlD
Carvedilol—CYP2E1—medulla oblongata—Behcet's disease	0.000746	0.00129	CbGeAlD
Carvedilol—ADRB1—brain—Behcet's disease	0.000728	0.00126	CbGeAlD
Carvedilol—KCNH2—nervous system—Behcet's disease	0.000727	0.00126	CbGeAlD
Carvedilol—ADRA1A—central nervous system—Behcet's disease	0.000725	0.00126	CbGeAlD
Carvedilol—ADRA2C—nervous system—Behcet's disease	0.000718	0.00125	CbGeAlD
Carvedilol—KCNH2—central nervous system—Behcet's disease	0.0007	0.00122	CbGeAlD
Carvedilol—ADRA2A—midbrain—Behcet's disease	0.000697	0.00121	CbGeAlD
Carvedilol—ADRA2C—central nervous system—Behcet's disease	0.000691	0.0012	CbGeAlD
Carvedilol—ADRA2A—spinal cord—Behcet's disease	0.00068	0.00118	CbGeAlD
Carvedilol—CYP2E1—spinal cord—Behcet's disease	0.000665	0.00115	CbGeAlD
Carvedilol—PTGS1—spinal cord—Behcet's disease	0.000641	0.00111	CbGeAlD
Carvedilol—CYP1A1—nervous system—Behcet's disease	0.000614	0.00107	CbGeAlD
Carvedilol—CYP1A1—central nervous system—Behcet's disease	0.000591	0.00103	CbGeAlD
Carvedilol—ABCB1—retina—Behcet's disease	0.000588	0.00102	CbGeAlD
Carvedilol—ADRA1A—brain—Behcet's disease	0.000576	0.000999	CbGeAlD
Carvedilol—ADRA2A—nervous system—Behcet's disease	0.000573	0.000994	CbGeAlD
Carvedilol—CYP2E1—nervous system—Behcet's disease	0.00056	0.000973	CbGeAlD
Carvedilol—KCNH2—brain—Behcet's disease	0.000556	0.000965	CbGeAlD
Carvedilol—ADRA2A—central nervous system—Behcet's disease	0.000551	0.000957	CbGeAlD
Carvedilol—ADRA2C—brain—Behcet's disease	0.000549	0.000952	CbGeAlD
Carvedilol—ADRA1D—GPCR ligand binding—CCR1—Behcet's disease	0.000542	0.00128	CbGpPWpGaD
Carvedilol—PTGS1—nervous system—Behcet's disease	0.00054	0.000937	CbGeAlD
Carvedilol—CYP2E1—central nervous system—Behcet's disease	0.000539	0.000936	CbGeAlD
Carvedilol—VEGFA—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000538	0.00127	CbGpPWpGaD
Carvedilol—ADRA1B—LPA receptor mediated events—CXCL8—Behcet's disease	0.000528	0.00125	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.000525	0.00124	CbGpPWpGaD
Carvedilol—PTGS1—central nervous system—Behcet's disease	0.00052	0.000902	CbGeAlD
Carvedilol—ADRB1—GPCR ligand binding—CCR1—Behcet's disease	0.000494	0.00116	CbGpPWpGaD
Carvedilol—PTGS1—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.00049	0.00116	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CCR1—Behcet's disease	0.000489	0.00115	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.000488	0.00115	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CCR1—Behcet's disease	0.000483	0.00114	CbGpPWpGaD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.000478	0.00113	CbGpPWpGaD
Carvedilol—ABCB1—mammalian vulva—Behcet's disease	0.00047	0.000817	CbGeAlD
Carvedilol—ADRB3—GPCR downstream signaling—CCR1—Behcet's disease	0.00047	0.00111	CbGpPWpGaD
Carvedilol—CYP1A1—brain—Behcet's disease	0.00047	0.000815	CbGeAlD
Carvedilol—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.000468	0.0011	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IL10—Behcet's disease	0.000466	0.0011	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CCR1—Behcet's disease	0.000457	0.00108	CbGpPWpGaD
Carvedilol—CYP3A4—nervous system—Behcet's disease	0.000451	0.000783	CbGeAlD
Carvedilol—ADRA1B—GPCR ligand binding—CCR1—Behcet's disease	0.00045	0.00106	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—HLA-B—Behcet's disease	0.000445	0.00105	CbGpPWpGaD
Carvedilol—CYP2D6—nervous system—Behcet's disease	0.000444	0.00077	CbGeAlD
Carvedilol—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	0.000443	0.00104	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—CAT—Behcet's disease	0.00044	0.00104	CbGpPWpGaD
Carvedilol—ADRA2A—brain—Behcet's disease	0.000438	0.00076	CbGeAlD
Carvedilol—CYP3A4—central nervous system—Behcet's disease	0.000434	0.000753	CbGeAlD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.000433	0.00102	CbGpPWpGaD
Carvedilol—CYP2E1—brain—Behcet's disease	0.000428	0.000743	CbGeAlD
Carvedilol—NDUFC2—Metabolism—APOB—Behcet's disease	0.000427	0.00101	CbGpPWpGaD
Carvedilol—CYP2D6—central nervous system—Behcet's disease	0.000427	0.000741	CbGeAlD
Carvedilol—ADRB3—Signaling by GPCR—CCR1—Behcet's disease	0.000427	0.00101	CbGpPWpGaD
Carvedilol—VEGFA—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000427	0.00101	CbGpPWpGaD
Carvedilol—ABCB1—medulla oblongata—Behcet's disease	0.000425	0.000737	CbGeAlD
Carvedilol—ADRA2B—Hemostasis—ITGB2—Behcet's disease	0.000416	0.000982	CbGpPWpGaD
Carvedilol—PTGS1—brain—Behcet's disease	0.000413	0.000716	CbGeAlD
Carvedilol—ADRA1A—GPCR ligand binding—CCR1—Behcet's disease	0.0004	0.000943	CbGpPWpGaD
Carvedilol—HIF1A—Disease—APOB—Behcet's disease	0.000393	0.000927	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—ITGB2—Behcet's disease	0.000389	0.000917	CbGpPWpGaD
Carvedilol—ABCB1—midbrain—Behcet's disease	0.000388	0.000674	CbGeAlD
Carvedilol—ABCB1—spinal cord—Behcet's disease	0.000379	0.000657	CbGeAlD
Carvedilol—ADRA2B—Hemostasis—ITGAL—Behcet's disease	0.000375	0.000886	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CCR1—Behcet's disease	0.000371	0.000876	CbGpPWpGaD
Carvedilol—CYP1A1—PPARA activates gene expression—APOA1—Behcet's disease	0.000364	0.000858	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—ICAM1—Behcet's disease	0.000361	0.000852	CbGpPWpGaD
Carvedilol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—Behcet's disease	0.000356	0.00084	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—ITGAL—Behcet's disease	0.000351	0.000827	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—APOB—Behcet's disease	0.00035	0.000827	CbGpPWpGaD
Carvedilol—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.000347	0.000819	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000342	0.000807	CbGpPWpGaD
Carvedilol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000342	0.000807	CbGpPWpGaD
Carvedilol—CYP2D6—brain—Behcet's disease	0.000339	0.000589	CbGeAlD
Carvedilol—NDUFC2—Metabolism—APOA1—Behcet's disease	0.000338	0.000797	CbGpPWpGaD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—TNF—Behcet's disease	0.000333	0.000784	CbGpPWpGaD
Carvedilol—ABCB1—nervous system—Behcet's disease	0.000319	0.000554	CbGeAlD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000317	0.000748	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—ITGB2—Behcet's disease	0.000316	0.000745	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—CXCL8—Behcet's disease	0.000314	0.00074	CbGpPWpGaD
Carvedilol—HIF1A—Disease—APOA1—Behcet's disease	0.000311	0.000734	CbGpPWpGaD
Carvedilol—ABCB1—central nervous system—Behcet's disease	0.000307	0.000533	CbGeAlD
Carvedilol—ADRA1D—GPCR downstream signaling—CCR1—Behcet's disease	0.000306	0.000722	CbGpPWpGaD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—TNF—Behcet's disease	0.000302	0.000711	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000296	0.000698	CbGpPWpGaD
Carvedilol—PTGS1—Selenium Micronutrient Network—TNF—Behcet's disease	0.000289	0.000681	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—ITGAL—Behcet's disease	0.000285	0.000672	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000283	0.000667	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CCR1—Behcet's disease	0.000279	0.000658	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CCR1—Behcet's disease	0.000278	0.000656	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—APOA1—Behcet's disease	0.000277	0.000654	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CCR1—Behcet's disease	0.000277	0.000652	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—APOB—Behcet's disease	0.000275	0.000649	CbGpPWpGaD
Carvedilol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000274	0.000647	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CCR1—Behcet's disease	0.000273	0.000644	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CCR1—Behcet's disease	0.000258	0.000609	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—NOS3—Behcet's disease	0.000256	0.000604	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000255	0.000601	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CCR1—Behcet's disease	0.000254	0.0006	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CCR1—Behcet's disease	0.000253	0.000598	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CCR1—Behcet's disease	0.000252	0.000595	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CCR1—Behcet's disease	0.000252	0.000594	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000252	0.000594	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CCR1—Behcet's disease	0.000251	0.000592	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CCR1—Behcet's disease	0.000248	0.000585	CbGpPWpGaD
Carvedilol—HIF1A—Disease—SERPINE1—Behcet's disease	0.000247	0.000582	CbGpPWpGaD
Carvedilol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—Behcet's disease	0.000245	0.000579	CbGpPWpGaD
Carvedilol—ABCB1—brain—Behcet's disease	0.000244	0.000423	CbGeAlD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000241	0.000567	CbGpPWpGaD
Carvedilol—HIF1A—Disease—NOS3—Behcet's disease	0.000236	0.000556	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000235	0.000554	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CCR1—Behcet's disease	0.000235	0.000553	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CCR1—Behcet's disease	0.000231	0.000545	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CCR1—Behcet's disease	0.000226	0.000533	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—SERPINE1—Behcet's disease	0.00022	0.000519	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000218	0.000514	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000218	0.000514	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—APOA1—Behcet's disease	0.000218	0.000514	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—NOS3—Behcet's disease	0.00021	0.000496	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CCR1—Behcet's disease	0.00021	0.000495	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—CXCL8—Behcet's disease	0.000209	0.000493	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—APOB—Behcet's disease	0.000207	0.000487	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCR1—Behcet's disease	0.000205	0.000484	CbGpPWpGaD
Carvedilol—ADRA2B—G alpha (i) signalling events—CXCL8—Behcet's disease	0.000203	0.000479	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—APOB—Behcet's disease	0.000193	0.000455	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000191	0.00045	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCR1—Behcet's disease	0.000191	0.000449	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—CXCL8—Behcet's disease	0.00019	0.000447	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000179	0.000421	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000177	0.000418	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000175	0.000413	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—SERPINE1—Behcet's disease	0.000173	0.000408	CbGpPWpGaD
Carvedilol—XDH—Metabolism—CAT—Behcet's disease	0.000172	0.000405	CbGpPWpGaD
Carvedilol—XDH—Metabolism—APOB—Behcet's disease	0.000167	0.000393	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—NOS3—Behcet's disease	0.000165	0.000389	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCR1—Behcet's disease	0.000164	0.000388	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—APOA1—Behcet's disease	0.000163	0.000385	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000163	0.000384	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000161	0.000381	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000159	0.000376	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—APOB—Behcet's disease	0.000157	0.00037	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—CXCL8—Behcet's disease	0.000154	0.000363	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—APOA1—Behcet's disease	0.000153	0.00036	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000151	0.000355	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCR1—Behcet's disease	0.00015	0.000353	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCR1—Behcet's disease	0.000148	0.00035	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000148	0.00035	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCR1—Behcet's disease	0.000146	0.000345	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—CXCL8—Behcet's disease	0.000146	0.000345	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000139	0.000327	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCR1—Behcet's disease	0.000139	0.000327	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCR1—Behcet's disease	0.000136	0.000322	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—CXCL8—Behcet's disease	0.000136	0.000321	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—TNF—Behcet's disease	0.000132	0.000312	CbGpPWpGaD
Carvedilol—XDH—Metabolism—APOA1—Behcet's disease	0.000132	0.000311	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000132	0.000311	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—SERPINE1—Behcet's disease	0.00013	0.000306	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—APOA1—Behcet's disease	0.000124	0.000292	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—CXCL8—Behcet's disease	0.000124	0.000292	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—NOS3—Behcet's disease	0.000124	0.000292	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000124	0.000291	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CXCL8—Behcet's disease	0.000123	0.00029	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000122	0.000289	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CXCL8—Behcet's disease	0.000121	0.000286	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—SERPINE1—Behcet's disease	0.000121	0.000286	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCR1—Behcet's disease	0.000121	0.000286	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—APOB—Behcet's disease	0.000119	0.000281	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—APOB—Behcet's disease	0.000119	0.00028	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—CXCL8—Behcet's disease	0.000118	0.000278	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—NOS3—Behcet's disease	0.000116	0.000273	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CXCL8—Behcet's disease	0.000115	0.000271	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CXCL8—Behcet's disease	0.000113	0.000266	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR1—Behcet's disease	0.000113	0.000265	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CXCL8—Behcet's disease	0.000107	0.000253	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CXCL8—Behcet's disease	0.0001	0.000237	CbGpPWpGaD
Carvedilol—XDH—Metabolism—NOS3—Behcet's disease	0.0001	0.000236	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—SERPINE1—Behcet's disease	9.84e-05	0.000232	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	9.77e-05	0.00023	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—APOA1—Behcet's disease	9.42e-05	0.000222	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—APOA1—Behcet's disease	9.4e-05	0.000222	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—NOS3—Behcet's disease	9.4e-05	0.000222	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	9.38e-05	0.000221	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CXCL8—Behcet's disease	9.32e-05	0.00022	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	9.22e-05	0.000217	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	8.75e-05	0.000206	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—CAT—Behcet's disease	8.06e-05	0.00019	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—CAT—Behcet's disease	8.04e-05	0.00019	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	7.88e-05	0.000186	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—APOB—Behcet's disease	7.82e-05	0.000184	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—APOB—Behcet's disease	7.81e-05	0.000184	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—APOB—Behcet's disease	7.76e-05	0.000183	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CXCL8—Behcet's disease	7.69e-05	0.000181	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SERPINE1—Behcet's disease	7.48e-05	0.000176	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SERPINE1—Behcet's disease	7.46e-05	0.000176	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	7.42e-05	0.000175	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	7.29e-05	0.000172	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NOS3—Behcet's disease	7.14e-05	0.000168	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NOS3—Behcet's disease	7.12e-05	0.000168	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—APOB—Behcet's disease	7.07e-05	0.000167	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CXCL8—Behcet's disease	7.01e-05	0.000165	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—APOB—Behcet's disease	7e-05	0.000165	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CXCL8—Behcet's disease	6.98e-05	0.000165	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CXCL8—Behcet's disease	6.94e-05	0.000164	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—APOB—Behcet's disease	6.91e-05	0.000163	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CXCL8—Behcet's disease	6.85e-05	0.000162	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CAT—Behcet's disease	6.54e-05	0.000154	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APOB—Behcet's disease	6.54e-05	0.000154	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CXCL8—Behcet's disease	6.49e-05	0.000153	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APOB—Behcet's disease	6.44e-05	0.000152	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CXCL8—Behcet's disease	6.38e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CXCL8—Behcet's disease	6.36e-05	0.00015	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOB—Behcet's disease	6.35e-05	0.00015	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CXCL8—Behcet's disease	6.33e-05	0.000149	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CXCL8—Behcet's disease	6.32e-05	0.000149	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CXCL8—Behcet's disease	6.3e-05	0.000149	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	6.23e-05	0.000147	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CXCL8—Behcet's disease	6.22e-05	0.000147	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—APOA1—Behcet's disease	6.19e-05	0.000146	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—APOA1—Behcet's disease	6.18e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—APOA1—Behcet's disease	6.14e-05	0.000145	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CAT—Behcet's disease	6.01e-05	0.000142	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CXCL8—Behcet's disease	5.89e-05	0.000139	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOB—Behcet's disease	5.83e-05	0.000138	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CXCL8—Behcet's disease	5.8e-05	0.000137	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOB—Behcet's disease	5.72e-05	0.000135	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CXCL8—Behcet's disease	5.67e-05	0.000134	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CAT—Behcet's disease	5.67e-05	0.000134	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—APOA1—Behcet's disease	5.59e-05	0.000132	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—APOA1—Behcet's disease	5.54e-05	0.000131	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOB—Behcet's disease	5.5e-05	0.00013	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—APOA1—Behcet's disease	5.47e-05	0.000129	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOB—Behcet's disease	5.31e-05	0.000125	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CXCL8—Behcet's disease	5.27e-05	0.000124	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APOA1—Behcet's disease	5.18e-05	0.000122	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CXCL8—Behcet's disease	5.15e-05	0.000121	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APOA1—Behcet's disease	5.09e-05	0.00012	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOA1—Behcet's disease	5.03e-05	0.000119	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SERPINE1—Behcet's disease	4.87e-05	0.000115	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CXCL8—Behcet's disease	4.78e-05	0.000113	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NOS3—Behcet's disease	4.69e-05	0.000111	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NOS3—Behcet's disease	4.68e-05	0.00011	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NOS3—Behcet's disease	4.65e-05	0.00011	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOA1—Behcet's disease	4.62e-05	0.000109	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CAT—Behcet's disease	4.53e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOA1—Behcet's disease	4.52e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SERPINE1—Behcet's disease	4.44e-05	0.000105	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SERPINE1—Behcet's disease	4.4e-05	0.000104	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOB—Behcet's disease	4.39e-05	0.000104	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOA1—Behcet's disease	4.35e-05	0.000103	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SERPINE1—Behcet's disease	4.34e-05	0.000102	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CAT—Behcet's disease	4.26e-05	0.000101	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NOS3—Behcet's disease	4.24e-05	9.99e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CAT—Behcet's disease	4.23e-05	9.97e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOA1—Behcet's disease	4.2e-05	9.91e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NOS3—Behcet's disease	4.2e-05	9.9e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NOS3—Behcet's disease	4.15e-05	9.78e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOB—Behcet's disease	4.14e-05	9.77e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CXCL8—Behcet's disease	4.13e-05	9.73e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SERPINE1—Behcet's disease	4.11e-05	9.69e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOB—Behcet's disease	4.1e-05	9.68e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SERPINE1—Behcet's disease	4.04e-05	9.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOS3—Behcet's disease	3.92e-05	9.25e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOS3—Behcet's disease	3.86e-05	9.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NOS3—Behcet's disease	3.81e-05	8.99e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CXCL8—Behcet's disease	3.76e-05	8.87e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CXCL8—Behcet's disease	3.72e-05	8.78e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CXCL8—Behcet's disease	3.68e-05	8.67e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CAT—Behcet's disease	3.61e-05	8.52e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SERPINE1—Behcet's disease	3.59e-05	8.47e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOB—Behcet's disease	3.51e-05	8.27e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—Behcet's disease	3.5e-05	8.25e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CXCL8—Behcet's disease	3.48e-05	8.21e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOA1—Behcet's disease	3.48e-05	8.2e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—Behcet's disease	3.43e-05	8.09e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CXCL8—Behcet's disease	3.42e-05	8.08e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SERPINE1—Behcet's disease	3.34e-05	7.87e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—Behcet's disease	3.3e-05	7.78e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOA1—Behcet's disease	3.28e-05	7.73e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOA1—Behcet's disease	3.25e-05	7.66e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—Behcet's disease	3.19e-05	7.51e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCL8—Behcet's disease	3.04e-05	7.17e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL8—Behcet's disease	2.83e-05	6.66e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CAT—Behcet's disease	2.79e-05	6.58e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOA1—Behcet's disease	2.77e-05	6.55e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOB—Behcet's disease	2.71e-05	6.38e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—Behcet's disease	2.63e-05	6.21e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—Behcet's disease	2.48e-05	5.86e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—Behcet's disease	2.46e-05	5.8e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOA1—Behcet's disease	2.14e-05	5.05e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—Behcet's disease	2.1e-05	4.96e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—Behcet's disease	1.62e-05	3.83e-05	CbGpPWpGaD
